Mr. Speaker, we are back debating Bill C-13, a very important bill, an act respecting assisted reproductive technologies and related research, as it came to be known. It started as Bill C-56 and our health committee spent a fairly extensive period of time discussing this issue. It came to us in a rather appropriate form as draft legislation. The health committee spent the better part of a year dealing with the very technical aspects of the bill. We came up with a report that we entitled “Assisted Human Reproduction: Building Families”. It was tabled in December 2001. We spent a lot of time dealing with this comprehensive report.
Today, the Group No. 3 amendments with which we are dealing address a significant aspect of the bill. There are quite a number of issues that are being addressed here that are important to the outcome and the application of the bill, and to the effect that it will have on Canadians and certainly on the industry. We want to address these important amendments that have been brought forward.
In our report “Assisted Human Reproduction: Building Families” members of the Standing Committee on Health were united in wanting an end to commercial surrogacy. It happens that the members for St. Paul's and Vancouver Centre were not members of the committee at the time, and these new members of the committee are responsible for some of the amendments that we will be addressing today. The report stated that:
It is contrary to our thinking to treat human beings or human material as commodities that can be regarded in terms of their economic value rather than their intrinsic worth. In particular, we feel that children can never be objects to be acquired or exchanged. Women and men need to know that their bodies and their reproductive material are not for sale or barter.
Some of the amendments that are being addressed here, particularly Motion No. 28 by the member for St. Paul's, would delete prohibitions on surrogacy from the prohibitions and would allow it to be dealt with in regulations, which would allow compensation and commercialization of this aspect of reproduction. Motion No. 29 from the member for Vancouver Centre would allow for the payment of legal and medical services.
There are aspects of the bill that we certainly, as a health committee, were not inclined to want to see advanced. For example, the payment for sperm and gametes. These amendments would allow for donor compensation, but basically we are talking about selling human cells and human life.
A website of a Canadian company working out of Toronto is offering sperm donors--although it is not called compensation, it is just for their expenses in making a donation--$65 per sample. It is recruiting on university campuses for young men to make a donation and allows them $65 for their trouble. They may leave up to three samples weekly. That would total about $200 a week for a university student. That is pretty good part time income we might say, about $800 a month for someone who wanted to take advantage of that.
Furthermore, successful donors are referred to the company by their friends or fellow students. Referrals can be an excellent source of revenue, it says here. If individuals are comfortable talking with others about being a donor, they receive a $10 referral fee for bringing in a friend, but if the friend is accepted as a qualified donor, they receive a $100 finders fee.
This is what our health committee was concerned about. We did not want to see human reproduction commodified. We did not want to see people selling human cells or human parts. For example, we do not pay a kidney donor for a kidney and we do not think we should be paying people for materials to produce babies or for babies themselves, as these amendments would allow.
I am quoting again from the committee report:
Women and men need to know that their bodies and their reproductive material are not for sale or barter. The Committee does not support any elements of trading, exchanging, buying or selling of human reproductive materials. We are aware that, in recent years, commodification, and in many respects, commercialization, have occurred in the field of assisted human reproduction. We want to ensure that the legislation will prevent the commodification of children, women's bodies, human reproductive material, and reproduction.
The fact is commercialization is already taking place in the United States. People who have a desperate need for a baby are able to buy one with the help of numerous surrogacy agencies.
A quick Internet search under “surrogacy” returns over 54,000 website hits revealing the vast amount of commercial businesses available to people who are willing to buy and sell babies. How much are people willing to pay for someone to have a baby for them? What should be an altruistic gift to an infertile couple could wind up costing that couple as much as $50,000 U.S. or even more if they want twins or a surrogate mother that is experienced.
How much can a woman sell her baby for? The going rate for a surrogate mother in the Untied States is about $20,000 U.S. and more if the woman has experience or if she is willing to carry twins.
Is that what we want to pursue in Canada, the buying and selling of children? That is really what it amounts to. That is what will happen if the amendments that the members would like to bring in are passed. They would take out the clauses that prevent sale, surrogacy and commodification. That is what will happen if the legislation is amended to reflect the motions put forward by the member for St. Paul's and the member for Vancouver Centre.
Ms. Phyllis Creighton is a member of the Health Canada Advisory Committee on the Interim Moratorium on Reproductive Technologies. She spoke to the health committee on September 25, 2001. I would like to reflect on some of her comments. She stated:
Canada should learn from the U.S. experience, with its unsavoury catalogues of surrogates and Internet marketing. Sound public policy must be based on the principle of the best interests of children. Baby brokers are not in the best interests of children.
Commercial surrogacy is vitiated by its morally unacceptable premise that a baby is a product to be exchanged and transferred for money. Brokers may claim that payment is for the reproductive service that the surrogate mother renders, but since she's not paid the full sum agreed to in the pre-conception arrangements until the baby is received into the custody of the commissioning parents, it is the baby who is being paid for.
Ms. Creighton concluded:
We do not pay the expenses of kidney donors for their donation in circumstances of life-threatening need. Childlessness is anguishing and worthy of compassionate help--
We certainly agree with her on that.
--but it is not a life-threatening condition. And it ought not to be done unless the best interests of children are secured.
The issues raised in these amendments are very important ones. There is donor compensation and whether we want to pay people for their gametes. Furthermore, other aspects of the bill allow for the import and export of gametes. Why, we might ask, would we allow for gametes to be imported from other countries where we cannot control the quality of the collection or the persons they are being collected from? We did hear evidence at committee that semen samples that are arriving at sperm banks in the U.S. are being sought out and also received from prisons in the United States.
Mr. Speaker, we are addressing some important aspects of the bill. I am wondering, given the importance of these amendments, whether I might receive unanimous consent from the members to continue my comments for five more minutes.